Clinical Trials

Search for actively enrolling clinical trials

A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination with Systemic Corticosteroids in Subjects with Non-ambulatory Duchenne Muscular Dystrophy (DMD)

Study ID: STU-2020-0249

Summary

nada!

Cancer Related
Healthy Volunteers
No
UT Southwestern Principal Investigator
DIANA PATRICIA CASTRO

Contact:

Kristy Riddle

Kristy.Riddle@UTSouthwestern.edu

Linked In Email
scroll to top